General Route to 2,4,5-Trisubstituted Piperidines
J . Org. Chem., Vol. 65, No. 19, 2000 6015
for 6 h before it was partitioned between 20 mL of CH2Cl2 and
10 mL of brine. The organic phase was separated, dried, and
concentrated, and the residue was chromatographed to give
graphed to give the corresponding ester. This ester was
dissolved in 1 mL of methanol and 0.5 mL of ethyl acetate,
and the solution was cooled to -25 °C. To this solution was
added 0.42 g of 6% sodium amalgam. The mixture was stirred
at this temperature for 1 h before the liquid was decanted into
water. The residue was washed with ethyl acetate for three
times, and the aqueous phase was extracted with ethyl acetate.
The combined organic phase was washed with brine and dried
over Na2SO4. After the solvent was evaporated, the residue
was chromatographed to give 31.7 mg (69%) of 19: [R]22D -47.6
1.55 g (85%) of 16. [R]15 -16.5 (c 3.2, CHCl3); IR (neat) 3460,
D
2933, 2859, 1740, 1695 cm-1
;
1H NMR (300 MHz, CDCl3) δ
7.65 (m, 4H), 7.39 (m, 6H), 4.55 (m, 1H), 4.32 (m, 1H), 3.95
(m, 1H), 3.72 (s, 3H), 3.63 (t, J ) 6.4 Hz, 2H), 3.43 (dm, J )
10.8 Hz, 1H), 2.95 (dd, J ) 13.2, 3.4 Hz, 1H), 2.83 (br s, 1H),
1.97 (m, 1H), 1.72 (m, 1H), 1.55 (m, 4H), 1.42 (s, 9H), 1.30 (m,
6H), 1.05 (s, 9H); MS m/z 498 (M+ - Boc + 2H+). Anal. Cacld
for C34H51NO6Si: C: 68.31, H: 8.60, N: 2.34. Found: C: 68.44,
H: 8.75, N: 2.00.
(c 0.82, CHCl3); IR (neat) 3300, 2932, 2859, 1749, 1674 cm-1
;
1H NMR (300 MHz, CDCl3) δ 5.95 (m, 2H), 5.50 (m, 3H), 4.92
(m, 1H), 4.10 (m, 2H), 3.95 (m, 1H), 2.88 (m, 1H), 2.21 (m,
1H), 2.02 (m, 4H), 1.84 (m, 1H), 1.44 (m, 2H), 1.39 (br s, 9H),
1.26 (m, 10H), 0.86 (t, J ) 6.4 Hz, 3H); MS m/z 420 (M+),
HRMS found m/z 420.3008 (M+); C24H40N2O4 requires 420.3028.
P seu d od istom in B Tr ia ceta te 20. To a solution of 19 (15
mg, 0.036 mmol) in 1 mL of methanol was added 1 mL of 10%
aqueous NaOH. The resultant mixture was refluxed for 3 h
before it was extracted with CH2Cl2. The combined organic
phase was dried and evaporated, and the residue was dissolved
in 2 mL of CH2Cl2. To this stirring solution were added 1 mg
of DMAP, 50 µL of Ac2O, and 50 µL of triethylamine. The
stirring was continued for 3 h, and then the solvent was
evaporated. The residue was chromatographed to give the
crude acylation product. This product was dissolved in 1 mL
of ethyl acetate, and then 1 mL of saturated methanolic HCl
was added. After the solution was stirred at room temperature
for 30 min, 3 mL of 20% aqueous K2CO3 was added to quench
the reaction. The resultant mixture was extracted with CH2Cl2,
and the combined organic phase was dried and concentrated.
The residue was dissolved in 1 mL of CH2Cl2 before 1 mg of
DMAP, 50 µL of Ac2O, and 50 µL of triethylamine were added.
The stirring was continued for 2 h, and then the solvent was
evaporated. The residue was chromatographed to give 10 mg
(3S ,4R ,6R )-6-(6-H y d r o x y h e x y l)-2-o x o h e x a h y d r o -
oxa zlolo[4,5-c]p ip er id in e-5-ca r boxylic Acid ter t-Bu tyl
Ester 17. To a solution of 16 (1.2 g, 2 mmol) in 3 mL of
methanol was added 3 mL of 10% NaOH solution. After the
mixture was stirred at room temperature for 6 h, methanol
was removed in vacuo. The residue was acidified to pH ) 4 by
adding 3 N HCl, and then the aqueous phase was extracted
with ethyl acetate. The combined organic phase was dried over
Na2SO4 and concentrated. After the residue was dissolved in
15 mL of dry benzene, DPPA (0.66 g, 2.4 mmol) and 1 mL of
triethylamine were added. The solution was heated at reflux
for 16 h, and then solvent was evaporated. The residue was
chromatographed to give the corresponding oxazolidinone,
which was dissolved in 5 mL of THF. After this solution was
added TBAF (0.65 g, 2.5 mmol), it was stirred at room
temperature for 6 h. The solvent was evaporated, and the
residue was chromatographed to provide 467 mg (68%) of 17:
[R]22D -63.8 (c 1.02, CHCl3); IR (neat) 3298, 2935, 2856, 1748,
1733, 1698 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.22 (br s, 1H),
4.91 (m, 1H), 4.04 (m, 2H), 3.95 (m, 1H), 3.64 (t, J ) 6.5 Hz,
2H), 2.87 (m, 2H), 2.27 (m, 1H), 1.56 (m, 3H), 1.45 (s, 9H),
1.33 (m, 8H); MS m/z 342 (M+), HRMS found m/z 342.2122
(M+), C17H30N2O5 requires 342.2090.
(3S,4R,6R)-2-Oxo-6-(8-oxooct-6-en yl)h exah ydr ooxazlolo-
[4,5-c]p ip er id in e-5-ca r boxylic Acid ter t-Bu tyl Ester 18.
To a solution of 17 (220 mg, 0.64 mmol) in 5 mL of CH2Cl2
was added Dess-Martin oxidant (330 mg, 0.78 mmol). The
solution was stirred at room temperature for 2 h before it was
filtered through silica gel. The filtrate was concentrated, and
the residue was chromatographed to give the corresponding
aldehyde, which was dissolved in 3.5 mL of dry ethyl ether
and 1.5 mL of dry THF. To this solution was added triphenyl-
arsonium salt of bromoacetaldehyde (338 mg, 0.96 mmol),
K2CO3 (106 mg, 0.77 mmol), and 30 µL of water. The resultant
mixture was stirred at room temperature for 20 h, and then
it was filtered through silica gel. The filtrate was concentrated,
(69%) of 20: [R]22 35.7 (c 1.0, CHCl3); 1H NMR (300 MHz,
D
CDCl3) δ 5.95 (m, 2H), 5.50 (m, 2H), 5.15 (br s, 1H), 4.92 (br
s, 3/4H), 4.61 (m, 1/4H), 4.51 (br s, 1/4H), 4.37 (br s, 3/4H),
4.01 (br s, 1/4H), 3.96 (m, 3/4H), 3.29 (m, 3/4H), 2.93 (m, 1/4H),
2.14 (br s, 2H), 2.04 (br s, 13H), 1.74 (m, 2H), 1.55 (m, 2H),
1.30 (br s, 10H), 0.89 (t, J ) 6.5 Hz, 3H); MS m/z 420 (M+).
(3S,4R,6S)-6-Hyd r oxym eth yl-2-oxoh exa h yd r ooxa zlolo-
[4,5-c]p ip er id in e-5-ca r boxylic Acid ter t-Bu tyl Ester 21.
To a stirring solution of 9e (1.2 g, 4.1 mmol) in 3 mL of CH2Cl2
were added tert-butyldiphenyl chloride (1.2 g, 4.4 mmol), 20
mg of DMAP, and 0.5 mL of triethylamine. The resultant
solution was stirred at room temperature for 6 h, and then it
was partitioned between 20 mL of CH2Cl2 and 10 mL of brine.
The organic phase was dried and concentrated, the residue
was chromatographed to give the corresponding silyl ether.
This silyl ether was dissolved in 3 mL of methanol, and then
3 mL of 10% aqueous NaOH was added. The mixture was
stirred at room temperature for 6 h before methanol was
removed in vacuo. The residue was added 3 N HCl to adjust
pH to 4, and then it was extracted with ethyl acetate. The
combined organic phase was dried over Na2SO4 and concen-
trated. The residue was dissolved in 15 mL of dry benzene,
and then DPPA (1.2 g, 4.4 mmol) and 1.5 mL of triethylamine
were added. After the resultant solution was heated at reflux
for 16 h, the cooled solution was concentrated, and the residue
was chromatographed to give the corresponding oxazolidinone,
which was dissolved in 3 mL of THF. After TBAF (1.2 g, 4.6
mmol) was added to this solution, it was stirred at room
temperature for 6 h. The solvent was evaporated, and the
residual oil was chromatographed to provide 0.59 g (52%) of
21: [R]21D -111.4 (c 0.92, CH3OH); IR (neat) 3456, 3298, 2970,
and the residue was chromatographed to give 172 mg (73%)
1
of unsaturated aldehyde 18: [R]22 -56.8 (c 1.0, CHCl3); H
D
NMR (300 MHz, CDCl3) δ 9.52 (d, J ) 7.8 Hz, 1H), 6.85 (dd,
J ) 15.6, 6.8 Hz, 1H), 6.12 (dd, J ) 15.6, 7.8 Hz, 1H), 5.60 (m,
1H), 4.92 (m, 1H), 4.1 (m, 2H), 3.95 (m, 1H), 2.88 (m, 1H), 2.33
(m, 3H), 1.61 (m, 3H), 1.44 (s, 9H), 1.32 (br s, 6H); MS m/z
366 (M+), HRMS found m/z 311.1634 (M+ - t-Bu + 2H+),
C
15H23N2O5 requires 311.1661.
(3S ,4R ,6R )-2-O x o -6-t r id e c a -6,8-d ie n y lh e x a h y d r o -
oxa zlolo[4,5-c]p ip er id in e-5-ca r boxylic Acid ter t-Bu tyl
Ester 19. A solution of n-pentyl phenyl sulfone (52 mg, 0.24
mmol) in 1 mL of dry THF was cooled to -78 °C, and then
n-BuLi (2 M solution in hexane, 0.24 mmol) was added. The
reaction mixture was stirred at this temperature for 2 h before
a solution of 18 (40 mg, 0.11 mmol) in 0.5 mL of dry THF was
added. The stirring was continued for another 1 h, and then 1
mL of saturated aqueous NH4Cl was added at -78 °C to
quench the reaction. After the mixture was warmed to room
temperature, the organic layer was separated, and the aqueous
layer was extracted with CH2Cl2. The combined organic layers
were washed with brine and dried over Na2SO4, the solvent
was evaporated, and the residue was chromatographed to give
the corresponding alcohol. This alcohol was dissolved in 1 mL
of dry CH2Cl2, and then benzoyl chloride (15.5 mg, 0.11 mmol),
1 mg of DMAP, and 20 mL of triethylamine were added. After
the solution was stirred at room temperature for 3 h, the
solvent was removed in vacuo, and the residue was chromato-
1
1744, 1671 cm-1; H NMR (300 MHz, CDCl3) δ 5.45 (m, 1H),
5.05 (m, 1H), 4.13 (m, 2H), 4.04 (m, 1H), 3.91 (m, 1H), 3.62
(m, 1H), 3.10 (m, 1H), 2.20 (m, 1H), 2.03 (m, 1H), 1.51 (br s,
9H); MS m/z 272 (M+); HRMS found m/z 272.1374, C12H20N2O5
requires 272.1376.
(3S ,4R ,6S )-6-Be n ze n e su lfon ylm e t h yl-2-oxoh e xa h y-
d r ooxa zlolo[4,5-c]p ip er id in e-5-ca r boxylic Acid ter t-Bu -
tyl Ester 22. To a stirring solution of 21 (110 mg, 0.4 mmol)
in 3 mL of CH2Cl2 were added MsCl (58 mg, 0.5 mmol), 2 mg